Immatics (IMTX) Competitors

Immatics (NASDAQ:IMTX) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

Which has higher earnings & valuation, IMTX or ALVO?

Immatics has higher earnings, but lower revenue than Alvotech. Immatics is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Immatics	$168.65M	4.30	$16.47M	-$0.17	-35.06
Alvotech	$491.98M	5.15	-$231.86M	$0.37	22.73

Does the media refer more to IMTX or ALVO?

In the previous week, Alvotech had 13 more articles in the media than Immatics. MarketBeat recorded 15 mentions for Alvotech and 2 mentions for Immatics. Immatics' average media sentiment score of 1.71 beat Alvotech's score of 0.63 indicating that Immatics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Immatics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Alvotech	2 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, IMTX or ALVO?

Immatics has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Alvotech has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500.

Is IMTX or ALVO more profitable?

Alvotech has a net margin of 16.42% compared to Immatics' net margin of -14.73%. Immatics' return on equity of -4.52% beat Alvotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Immatics	-14.73%	-4.52%	-3.34%
Alvotech	16.42%	-36.37%	12.70%

Do institutionals & insiders hold more shares of IMTX or ALVO?

64.4% of Immatics shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts prefer IMTX or ALVO?

Immatics currently has a consensus price target of $14.67, suggesting a potential upside of 146.09%. Alvotech has a consensus price target of $18.00, suggesting a potential upside of 114.03%. Given Immatics' stronger consensus rating and higher probable upside, research analysts plainly believe Immatics is more favorable than Alvotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Immatics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Alvotech	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Immatics beats Alvotech on 9 of the 16 factors compared between the two stocks.